Spurred by a lifelong passion for space, medicine, and engineering, I am excited to announce the launch of Skybound Medtech. Backed by $5M in early committed capital towards a $25M initial raise and partnering with Texas A&M School of Engineering Medicine (EnMed) / EnGen, Rice Innovation & Rice Nexus, University City Science Center, SATOP, and a few more to be announced in the coming weeks, Skybound Medtech is developing a portfolio of transformative dual-use medical technologies at the intersection of space medicine, longevity medicine, and national defense.

We stand at the precipice of a burgeoning industrial revolution. The commercial space economy is projected to surge to $1 trillion by the early 2030s. This exponential growth curve is fueled by a twenty-fold increase in venture investment into space companies since 2016, driven largely by the plummeting costs of launch via reusable rocketry, efforts by nations around the world to develop sovereign military space capabilities, a rapidly growing market for space tourism, and the promise of new super materials enabled by in-space manufacturing.

However, while the infrastructure for reaching orbit continues to mature, the ability to keep humans in space is impaired by a critical bottleneck: human physiology. The deterioration of the human body in the extreme environment of space mirrors accelerated aging. The symptoms experienced by astronauts - bone loss, muscle wasting, vestibular decay - are clinically identical to natural aging on Earth. By engineering solutions to sustain human health in orbit, we are validating transformative longevity therapeutics for aging populations and autonomous healthcare solutions for austere environments on Earth.

We are proudly headquartered in Houston, Texas - the only city on the planet that offers a world-class, co-located ecosystem in life sciences (Texas Medical Center), human spaceflight (NASA's Johnson Space Center), and venture capital.

Over the next decade, Skybound will launch ten new medtech startups, each strategically focused on dual-use medical technologies to transform the standard of care for disease treatment and prevention while simultaneously paving the way for the Second Space Age. These startups will create 100+ new jobs and drive a self-sustaining influx of talent, investment, and non-dilutive capital into the Texas economy.